Yiling is a PhD candidate working in collaboration with the Laboratory for Advanced Biomaterials & Matrix Engineering and the Centre of Macromolecular Design at the University of New South Wales. She has a strong interest in using tissue engineering to improve the understanding of growth and progression in cancer. She believes this will improve the matching of patients to therapeutics with a high probability of being efficacious for their disease subtype. Her doctoral research aims to create tissue engineered melanoma models that replicate patient tumour characteristics for the development of therapies that attenuate resistance and disrupt metastatic processes.
As a Fulbright Scholar, Yiling will extend her research at the Cancer Biology and Translational Research Laboratory at Mayo Clinic’s campus in Florida. She aims to develop a microtumour array with patient derived cells for high-throughput evaluation of novel cancer therapies including nanomedicines, biomedicines, and combinational drug therapies.